Your browser doesn't support javascript.
loading
Predictors of mortality among drug-resistant tuberculosis patients in Kaduna State, Nigeria.
Oyefabi, A M; Tobin West, C I; Ameh, S; Jiya, E N; Sadiq, A; Dauda, H; Onoh, M.
  • Oyefabi AM; Department of Community Medicine, College of Medicine, Zaria, Nigeria.
  • Tobin West CI; College of Health Sciences and School of Public Health, University of Port Harcourt, Minna, Nigeria.
  • Ameh S; Department of Community Medicine, University of Calabar, Cross River State, Minna, Nigeria.
  • Jiya EN; National Tuberculosis and Leprosy Training Centre, Zaria, Nigeria.
  • Sadiq A; Tuberculosis Unit, Kaduna State Ministry of Health, Kaduna State, Nigeria.
  • Dauda H; World Health Organization, Niger State Field Office, Minna, Nigeria.
  • Onoh M; Communicable and Non Communicable Diseases Cluster, World Health Organization, Nigeria.
Niger J Clin Pract ; 26(6): 825-831, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37470659
ABSTRACT

Background:

Specific death due to DR-TB has significantly contributed to tuberculosis (TB) mortality and overall global deaths.

Aim:

This study examines the predictors of mortality among DR-TB patients in Kaduna State, Nigeria. Subject and

Method:

This was a retrospective longitudinal study of DR-TB mortality carried out among 370 DR-TB patients from the 23 LGAs in Kaduna State. It involves a retrospective review of the MDR-TB records of the patients over a period of 10 years (2012-2021). Demographic and clinical data of all DR-TB patients enrolled in Kaduna State, Nigeria, between April 1, 2012, and March 31, 2021, were used. Survival analysis was performed with SPSS version 25, using Kaplan-Meier and Cox proportional hazard regression modeling, at 5% significance level.

Results:

The majority of the patients, 255 (68.9%), were below the age of 40 years, while 53 (14.3%) of the patients died within the study period. Most deaths 26 (49.1%) were associated with HIV co-infection and the disease severity. Results for the Cox proportional model show that there was a significantly lower risk of death when a patient had MDR-TB compared to pre-XDR-TB (adjusted hazard ratio, AHR = 0.34, 95% CI = 0.16-0.72, P = 0.04). Both models show that age, sex, residence, or year of treatment had no significant association with survival or death.

Conclusion:

HIV co-infection and DRTB with progression to more resistant and difficult-to-treat strains contributed to higher deaths. There is a need for concerted efforts from all DR-TB stakeholders to control the disease.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / Tuberculosis Resistente a Múltiples Medicamentos / Coinfección Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País como asunto: Africa Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / Tuberculosis Resistente a Múltiples Medicamentos / Coinfección Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans País como asunto: Africa Idioma: En Año: 2023 Tipo del documento: Article